SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-092679
Filing Date
2019-03-29
Accepted
2019-03-29 16:13:33
Documents
9
Period of Report
2019-03-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d730757d8k.htm 8-K 24414
2 EX-4.1 d730757dex41.htm EX-4.1 74807
3 EX-4.2 d730757dex42.htm EX-4.2 66143
4 EX-5.1 d730757dex51.htm EX-5.1 14033
5 EX-5.2 d730757dex52.htm EX-5.2 13501
6 EX-10.1 d730757dex101.htm EX-10.1 75519
7 EX-10.2 d730757dex102.htm EX-10.2 41557
8 GRAPHIC g730757g0328095301988.jpg GRAPHIC 2563
9 GRAPHIC g730757g77p33.jpg GRAPHIC 3128
  Complete submission text file 0001193125-19-092679.txt   319242
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37708 | Film No.: 19716567
SIC: 2834 Pharmaceutical Preparations